Global Markets and Technologies for Molecular Imaging Devices

Report Highlights

The global market for molecular imaging devices was valued at $2 billion in 2012. This market is expected to reach $2.2 billion in 2013 and nearly $3 billion by 2018, with a compound annual growth rate (CAGR) of 6.2% for the period of 2013 to 2018.

Report Includes

• An overview of the global market for molecular imaging devices, which offers a new dimension to medicine as it evolves toward more personalized forms of treatment.
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period 2013 to 2018.
• Examination of factors driving growth, market figures related to the current value of molecular imaging equipment, market shares, and key players.
• Reviews of the competitive landscape, leading pipeline products, pricing, and technology offerings.
• Identification of the types of molecular imaging devices, including stand-alone planar imaging, PET, PET-CT, SPECT, and SPECT-CT.
• Comprehensive company profiles of major manufacturers.

SCOPE OF STUDY

This report is a comprehensive business tool designed to provide an in–depth look at molecular imaging devices for various applications. The geographic scope of the report is global, with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare industry and its participants and trends for the future.

Categories discussed in the report include:

• Planar scintillation cameras.
• PET.
• PET–CT.
• SPECT.
• SPECT–CT.

Applications discussed in the report include:

• Oncology.
• Cardio and vascular.
• Neurology.
• Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging).

All categories are discussed in detail, describing each segment, identifying current products in the market, measuring market size, identifying market drivers, forecasting for 2013 through 2018 and assessing the competitors and competitor market shares. For country–level breakdown of segments, only the base year 2013 and projections through 2018 are shown in the data tables.

The market evaluated in this study pertains to new nuclear medicine and PET imaging systems that are developed and approved for human clinical use. The market sizing only takes into account the new equipment. Options/upgrades or refurbished/remarketed equipment have not been accounted for in the quantitative estimates and forecasts provided in the study. Ancillary products and services, including contrast agents, radiopharmaceuticals, licensing fees, cyclotrons, radiotherapy equipment, and mobile imaging devices have been excluded from the study. Also, integrated PET/MRI systems are not accounted for in forecasts pertaining to the market segment.

ANALYST CREDENTIALS

Smruti Munshi is a research analyst who has specialized in the medical technologies space for the last five years. She focuses on monitoring and analyzing emerging trends, technologies, competitive benchmarking and market dynamics in the medical imaging industry. She has worked on several projects spanning the EMEA markets ranging from market insights, and industry overviews to comprehensive marketing and technology–oriented custom consulting. Ms. Munshi has an M.S. in Biomedical Engineering and a B.S. in Instrumentation and Control Engineering.